Subclinical central inflammation is risk for RIS and CIS conversion to MS

  title={Subclinical central inflammation is risk for RIS and CIS conversion to MS},
  author={Silvia Rossi and Caterina Motta and Valeria Studer and Giulia Macchiarulo and Giorgio Germani and Annamaria Finardi and Roberto Furlan and Gianvito Martino and Diego Centonze},
  journal={Multiple Sclerosis Journal},
  pages={1443 - 1452}
Background: Subtle diffuse intrathecal inflammation is undetectable by conventional neuroimaging, and could influence multiple sclerosis (MS) disease course. Objective: To explore the role of subclinical persisting intrathecal inflammation in radiologically isolated syndrome (RIS) or clinically isolated syndrome (CIS) conversion to MS, and in early MS disease reactivation. Methods: One-hundred ninety-three subjects with RIS, CIS, relapsing–remitting (RR), or primary progressive (PP) MS were… 

Figures and Tables from this paper

Biological Markers in Early Multiple Sclerosis: the Paved Way for Radiologically Isolated Syndrome

Biological markers that may help refine the risk stratification of clinical MS and disability for early treatment are focused on, as early as possible, for predicting greater disease severity.

[Radiologically isolated syndrome: prognosis and predictors of conversion to multiple sclerosis].

The identification of the molecular biological RIS features, combining these changes with MS, is an urgent scientific task and will allow timely initiation of therapy of the pathological process already at the subclinical stage.

Analysis of factors correlated with spinal clinically isolated syndrome conversion to multiple sclerosis.

Patients with spinal CIS with pure sensory abnormalities at onset were less likely to convert to MS, and the risk factors were, in order of risk, the difference in EDSS score before and after steroid therapy (≥ 1.5).

Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course

Delayed diagnosis and treatment initiation are associated with higher CSF levels of IL-6 and IL-8 in RR-MS, leading to worsening disease course and poor response to treatments.

IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis

It is found that IL-6 was more frequently detectable in the CSF of MS patients compared with their control counterparts as significant differences emerged between patients with Clinically isolated syndrome, Relapsing–remitting (RR), and secondary progressive and primary progressive MS compared to non-inflammatory controls.

Radiologically isolated syndrome and multiple sclerosis.

Secondary Prevention in Radiologically Isolated Syndromes and Prodromal Stages of Multiple Sclerosis

Following the extraordinary progress in the treatment of multiple sclerosis (MS), two major unmet needs remain: understanding the etiology of the disease and, hence, designing definitive cures (this

Drug Treatment of Clinically Isolated Syndrome

The available data on the efficacy, safety and tolerability of DMTs tested for CIS are reviewed and their value regarding a delay of progression to CDMS is discussed.

Radiologically isolated syndrome and clinically isolated syndrome

The present review discusses the current concepts of RIS and CIS, and the risk factors for conversion from these conditions to MS, and that early treatment with these drugs could improve future disease prognosis in patients who subsequently developed MS.

Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients

There is a pressing need to provide an update on the main prognostic factors that increase the risk of conversion from CIS or from radiologically isolated syndrome to MS, and on the potential ‘red flags' to consider during the diagnostic workup.



Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS

TheChemokine CXCL13 may play a major role in recruitment of B cells and T-cell subsets expressing the chemokine receptor CXCR5 to the CNS in multiple sclerosis (MS), and may be a useful biomarker for treatment effects in MS.

Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis

Higher frequency of lesion occurrence in clinically eloquent WM tracts can characterize CIS subjects with different types of onset, and the involvement of specific WM tracts, in particular those traversed by fibers involved in motor function and near the corpus callosum seems to be associated with a higher risk of clinical conversion to MS in the short term.

Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome

It is suggested that the presence of asymptomatic spinal cord lesions place subjects with RIS at substantial risk for clinical conversion to either an acute or progressive event, a risk that is independent of brain lesions on MRI.

Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event

Data provide supportive evidence that a meaningful number of RIS subjects evolve to a first clinical symptom, and an age <37 y, male sex, and spinal cord involvement appear to be the most important independent predictors of symptom onset.

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)

The data indicate the relevance of CXCL13 in CIS to predict conversion to MS and shows CxCL13 to be an important mediator in the inflammatory cascade associated with the polyspecific intrathecal B cell response that manifests itself in OCB and MRZR.

Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.

Examination of pejorative markers for clinical conversion showed that sex, number of T2 lesions, presence of oligoclonal bands, and IgG index were not statistically different in patients with MS determined by MRI compared with clinically definite MS.

The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability

Investigation of relationships between relapses and disability progression for outcomes of needing assistance to walk, being bedridden and dying from MS by analysing 28 000 patient-years of disease evolution in 806 bout onset patients from the London Ontario natural history cohort finds no deleterious effect on outcomes.

Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation

Future clinical studies will determine if a combinatorial biomarker consisting of CSF IL-12p40, CXCL13 and IL-8 provides utility in determining the presence of active intrathecal inflammation in diagnostically uncertain cases and in therapeutic development and management.

Differential diagnosis of suspected multiple sclerosis: a consensus approach

Background and objectives Diagnosis of multiple sclerosis (MS) requires exclusion of diseases that could better explain the clinical and paraclinical findings. A systematic process for exclusion of